Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
J Protein Chem
2000 Aug 01;196:475-87. doi: 10.1023/a:1026549431380.
Show Gene links
Show Anatomy links
Light chain of botulinum A neurotoxin expressed as an inclusion body from a synthetic gene is catalytically and functionally active.
Ahmed SA
,
Smith LA
.
???displayArticle.abstract???
Botulinum neurotoxins, the most potent of all toxins, induce lethal neuromuscular paralysis by inhibiting exocytosis at the neuromuscular junction. The light chains (LC) of these dichain neurotoxins are a new class of zinc-endopeptidases that specifically cleave the synaptosomal proteins, SNAP-25, VAMP, or syntaxin at discrete sites. To facilitate the structural and functional characterization of these unique endopeptidases, we constructed a synthetic gene for the LC of the botulinum neurotoxin serotype A (BoNT/A), overexpressed it in Escherichia coli, and purified the gene product from inclusion bodies. Our procedure can provide 1.1 g of the LC from 1 L of culture. The LC product was stable in solution at 4 degrees C for at least 6 months. This rBoNT/A LC was proteolytically active, specifically cleaving the Glu-Arg bond in a 17-residue synthetic peptide of SNAP-25, the reported cleavage site of BoNT/A. Its calculated catalytic efficiency kcat/Km was higher than that reported for the native BoNT/A dichain. Treating the rBoNT/A LC with mercuric compounds completely abolished its activity, most probably by modifying the cysteine-164 residue located in the vicinity of the active site. About 70% activity of the LC was restored by adding Zn2+ to a Zn2+-free, apo-LC preparation. The LC was nontoxic to mice and failed to elicit neutralizing epitope(s) when the animals were vaccinated with this protein. In addition, injecting rBoNT/A LC into sea urchin eggs inhibited exocytosis-dependent plasma membrane resealing. For the first time, results of our study make available a large amount of the biologically active toxin fragment in a soluble and stable form.
Andersson,
Codon preferences in free-living microorganisms.
1990, Pubmed
Andersson,
Codon preferences in free-living microorganisms.
1990,
Pubmed
Auld,
Removal and replacement of metal ions in metallopeptidases.
1995,
Pubmed
Bi,
Calcium-regulated exocytosis is required for cell membrane resealing.
1995,
Pubmed
,
Echinobase
Bittner,
Isolated light chains of botulinum neurotoxins inhibit exocytosis. Studies in digitonin-permeabilized chromaffin cells.
1989,
Pubmed
Black,
Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis.
1986,
Pubmed
Blasi,
Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
1993,
Pubmed
Cai,
Enhancement of the endopeptidase activity of botulinum neurotoxin by its associated proteins and dithiothreitol.
1999,
Pubmed
Chen,
Antibody mapping to domains of botulinum neurotoxin serotype A in the complexed and uncomplexed forms.
1997,
Pubmed
DasGupta,
C. botulinum neurotoxin types A and E: isolated light chain breaks down into two fragments. Comparison of their amino acid sequences with tetanus neurotoxin.
1989,
Pubmed
DasGupta,
Botulinum neurotoxin type A: sequence of amino acids at the N-terminus and around the nicking site.
1990,
Pubmed
Dertzbaugh,
Mapping of protective and cross-reactive domains of the type A neurotoxin of Clostridium botulinum.
1996,
Pubmed
Foran,
Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments.
1994,
Pubmed
Foran,
Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release.
1996,
Pubmed
Fu,
Role of zinc in the structure and toxic activity of botulinum neurotoxin.
1998,
Pubmed
Kiyatkin,
Induction of an immune response by oral administration of recombinant botulinum toxin.
1997,
Pubmed
Kurazono,
Minimal essential domains specifying toxicity of the light chains of tetanus toxin and botulinum neurotoxin type A.
1992,
Pubmed
Lacy,
Crystal structure of botulinum neurotoxin type A and implications for toxicity.
1998,
Pubmed
Lacy,
Sequence homology and structural analysis of the clostridial neurotoxins.
1999,
Pubmed
Laemmli,
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
1970,
Pubmed
Lebeda,
Secondary structural predictions for the clostridial neurotoxins.
1994,
Pubmed
Li,
High-level expression, purification, and characterization of recombinant type A botulinum neurotoxin light chain.
1999,
Pubmed
Li,
A single mutation in the recombinant light chain of tetanus toxin abolishes its proteolytic activity and removes the toxicity seen after reconstitution with native heavy chain.
1994,
Pubmed
Maisey,
Involvement of the constituent chains of botulinum neurotoxins A and B in the blockade of neurotransmitter release.
1988,
Pubmed
Makoff,
Expression of tetanus toxin fragment C in E. coli: high level expression by removing rare codons.
1989,
Pubmed
Montal,
Identification of an ion channel-forming motif in the primary structure of tetanus and botulinum neurotoxins.
1992,
Pubmed
Montecucco,
Mechanism of action of tetanus and botulinum neurotoxins.
1994,
Pubmed
Montecucco,
Structure and function of tetanus and botulinum neurotoxins.
1995,
Pubmed
Nowakowski,
Production of an expression system for a synaptobrevin fragment to monitor cleavage by botulinum neurotoxin B.
1998,
Pubmed
Rossetto,
SNARE motif and neurotoxins.
1994,
Pubmed
Schiavo,
Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E.
1993,
Pubmed
Schiavo,
Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single Ala-Ala peptide bond.
1994,
Pubmed
Schiavo,
Intracellular targets and metalloprotease activity of tetanus and botulism neurotoxins.
1995,
Pubmed
Schmidt,
Proteolysis of synthetic peptides by type A botulinum neurotoxin.
1995,
Pubmed
Schmidt,
Endoproteinase activity of type A botulinum neurotoxin: substrate requirements and activation by serum albumin.
1997,
Pubmed
Shone,
Peptide substrate specificity and properties of the zinc-endopeptidase activity of botulinum type B neurotoxin.
1994,
Pubmed
Shone,
Proteolytic cleavage of synthetic fragments of vesicle-associated membrane protein, isoform-2 by botulinum type B neurotoxin.
1993,
Pubmed
Shone,
Growth of clostridia and preparation of their neurotoxins.
1995,
Pubmed
Smith,
Development of recombinant vaccines for botulinum neurotoxin.
1998,
Pubmed
Steinhardt,
Cell membrane resealing by a vesicular mechanism similar to neurotransmitter release.
1994,
Pubmed
,
Echinobase
Syuto,
Separation and characterization of heavy and light chains from Clostridium botulinum type C toxin and their reconstitution.
1981,
Pubmed
Thompson,
The complete amino acid sequence of the Clostridium botulinum type A neurotoxin, deduced by nucleotide sequence analysis of the encoding gene.
1990,
Pubmed
Washbourne,
Botulinum neurotoxin types A and E require the SNARE motif in SNAP-25 for proteolysis.
1997,
Pubmed
Winkler,
Codon usage in selected AT-rich bacteria.
1988,
Pubmed
Zhou,
Expression and purification of the light chain of botulinum neurotoxin A: a single mutation abolishes its cleavage of SNAP-25 and neurotoxicity after reconstitution with the heavy chain.
1995,
Pubmed
de Paiva,
A role for the interchain disulfide or its participating thiols in the internalization of botulinum neurotoxin A revealed by a toxin derivative that binds to ecto-acceptors and inhibits transmitter release intracellularly.
1993,
Pubmed
